Clinical Trials Update: May 7, 2008 (HealthDay) Posted on May 11th
The purpose of this clinical research study is to compare the medium
dose of an FDA-approved combination drug with the higher dose of an
FDA-approved combination drug for blood pressure control in patients who
have failed to have their blood pressure controlled on a single
antihypertensive agent.
Trackback URL